Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

CARLSMED, INC. (CARL)

  • Business News
  • May 05, 2026, 20:01 UTC
  • 1
  • 1 comments

Carlsmed® Reports First Quarter 2026 Financial Results

Market reaction Comment Full text

HYPERION DEFI, INC. (HYPD)

  • Business News
  • May 05, 2026, 20:01 UTC
  • 1
  • 1 comments

Hyperion DeFi Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Market reaction Comment Full text

MONTE ROSA THERAPEUTICS, INC. (GLUE)

  • Business News
  • May 05, 2026, 20:01 UTC
  • 0
  • 1 comments

Monte Rosa Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Market reaction Comment Full text

BJ''S WHOLESALE CLUB HOLDINGS, INC. (BJ)

  • Business News
  • May 05, 2026, 20:01 UTC
  • 0
  • 1 comments

BJ’s Wholesale Club Fort Worth Location Set to Open on May 8

Market reaction Comment Full text

TEMPUS AI, INC. (TEM)

  • Business News
  • May 05, 2026, 20:01 UTC
  • 1
  • 1 comments

Tempus Reports First Quarter 2026 Results

Market reaction Comment Full text

SILVERCREST ASSET MANAGEMENT GROUP INC. (SAMG)

  • Business News
  • May 05, 2026, 20:01 UTC
  • 0
  • 1 comments

Silvercrest Asset Management (SAMG) to Announce First Quarter 2026 Results and Host Investor Conference Call

Market reaction Comment Full text

MERCURY SYSTEMS INC (MRCY)

  • Business News
  • May 05, 2026, 20:01 UTC
  • 1
  • 1 comments

Mercury Systems Reports Third Quarter Fiscal 2026 Results

Market reaction Comment Full text

LIGAND PHARMACEUTICALS INC (LGND)

  • Business News
  • May 05, 2026, 20:01 UTC
  • 0
  • 1 comments

Ligand to Participate in May Investor Conferences

Market reaction Comment Full text

GULFPORT ENERGY CORP (GPOR)

  • Business News
  • May 05, 2026, 20:01 UTC
  • 1
  • 1 comments

Gulfport Energy Appoints Domenic J. Dell’Osso, Jr. Chief Executive Officer

Market reaction Comment Full text

AVALO THERAPEUTICS, INC. (AVTX)

  • Business News
  • May 05, 2026, 20:01 UTC
  • 1
  • 1 comments

Avalo Therapeutics Achieves Positive Topline Results in Phase 2 LOTUS Trial of Abdakibart (AVTX-009) in Moderate to Severe Hidradenitis Suppurativa

Market reaction Comment Full text
  • Previous
  • 269
  • 270
  • 271
  • 272
  • 273
  • Next

Search

News categories

  • Technical Exchange News(12354)
  • Event(6229)
  • SEC News(271822)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158053)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin